Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 versus azathioprine and placebo for maintenance of steroid-free remission in Crohn's disease
2005-001148-22Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing Certican arm, Imuran arm and Placebo arm (3 arms). Primary endpoints: Primary efficacy variable and Treatment success definition. Started May 2005; status: completed.
02
Drugs
everolimusazathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-001148-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001148-22.